Early Temozolomide in Patients With High-Grade Gliomas in Rehabilitation
Status:
Withdrawn
Trial end date:
2021-12-15
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the feasibility of a possible treatment regimen
that could be used to delay tumor progression in patients with glioblastoma. The study is
being conducted in patients who qualify for inpatient rehabilitation, as this population is
particularly vulnerable to delays in initiation of chemoradiation and further tumor growth in
the period between surgical resection and the start of treatment.